VanEck Vectors Performance

VanEck Vectors Biotech ETF -- USA Etf  

USD 133.27  1.7  1.29%

The entity has beta of -0.7837 which indicates as returns on market increase, returns on owning VanEck Vectors are expected to decrease at a much smaller rate. During bear market, VanEck Vectors is likely to outperform the market.. Although it is vital to follow to VanEck Vectors Biotech current price movements, it is good to be conservative about what you can actually do with the information regarding equity historical returns. The philosophy towards measuring future performance of any etf is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. By inspecting VanEck Vectors Biotech technical indicators you can presently evaluate if the expected return of 0.2599% will be sustainable into the future.
 Time Horizon     30 Days    Login   to change

VanEck Vectors Biotech Relative Risk vs. Return Landscape

If you would invest  12,534  in VanEck Vectors Biotech ETF on December 24, 2017 and sell it today you would earn a total of  623  from holding VanEck Vectors Biotech ETF or generate 4.97% return on investment over 30 days. VanEck Vectors Biotech ETF is generating 0.2599% of daily returns assuming volatility of 0.9508% on return distribution over 30 days investment horizon. In other words, 8% of equities are less volatile than the company and above 96% of equities are expected to generate higher returns over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 
Considering 30-days investment horizon, VanEck Vectors Biotech ETF is expected to generate 1.12 times less return on investment than the market. In addition to that, the company is 2.05 times more volatile than its market benchmark. It trades about 0.27 of its total potential returns per unit of risk. The DOW is currently generating roughly 0.63 per unit of volatility.

Price to Book

VanEck Vectors Biotech Price to Book
Based on latest financial disclosure the price to book indicator of VanEck Vectors Biotech ETF is roughly 2.74 times. This is 211.36% higher than that of the Van Eck family, and about the same as Health (which currently averages 2.76) category, The Price to Book for all etfs is 182.47% lower than the firm.
  to Book 
      VanEck Vectors Comparables 
Price to Book ratio is mostly used in financial services industries where assets and liabilities are typically represented by dollars. Although low Price to Book ratio generally implies that the firm is undervalued, it is often a good indicator that the company may be in financial or managerial distress and should be investigated more carefully.

VanEck Vectors Daily Price Distribution

The median price of VanEck Vectors for the period between Sun, Dec 24, 2017 and Tue, Jan 23, 2018 is 128.33 with a coefficient of variation of 1.48. The daily time series for the period is distributed with a sample standard deviation of 1.89, arithmetic mean of 127.52, and mean deviation of 1.65. The Etf did not receive any noticable media coverage during the period.

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in VanEck Vectors Biotech ETF are ranked lower than 17 (%) of all global equities and portfolios over the last 30 days.

One Month Efficiency

VanEck Vectors Sharpe Ratio = 0.2733
Good Returns
Average Returns
Small ReturnsBBH
Negative Returns

Estimated Market Risk

  actual daily
 92 %
of total potential

Expected Return

  actual daily
 4 %
of total potential

Risk-Adjusted Return

  actual daily
 17 %
of total potential
Based on monthly moving average VanEck Vectors is performing at about 17% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of VanEck Vectors by adding it to a well-diversified portfolio.


VanEck Vectors Biotech Dividends Analysis
Check VanEck Vectors Biotech dividend payout schedule and payment analysis over time. Analyze past dividends calendar and estimate annual dividend income
Check Dividends